Search

everythinglearnresearchcommunity

for

Search:↓

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

Estrogen alone can lower testosterone in some transfeminine people.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Ficus carica extract improved fertility in rats and may help with certain health conditions.

Cyproterone acetate is effective for acne but less so for hirsutism and alopecia, with some side effects and quick menstrual cycle recovery after treatment.

The method detected sex hormones in some health supplements, with one containing banned testosterone.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

EF and PXE not closely related.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Women with different PCOS types have similar fertility treatment results.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Minoxidil helps regrow hair in female pattern hair loss, but more research needed for other treatments.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.